(+)-Dibenzoyl-D-Tartaric Acid Monohydrate, also known as DBDTA monohydrate, is a chiral organic compound that belongs to the class of tartaric acid derivatives. It is widely used in the pharmaceutical industry as a resolving agent for racemic mixtures of basic compounds. DBDTA monohydrate is a white crystalline powder with a molecular weight of 386.32 g/mol. It has a melting point of 176-180℃ and is soluble in water and ethanol. DBDTA monohydrate has two stereo centers that give rise to four stereoisomers, of which only the (+)-enantiomer is used in the pharmaceutical industry. DBDTA monohydrate acts as an effective resolving agent for many basic compounds such as amino acids, alkaloids, and synthetic drugs. It selectively forms diastereomeric salts with the racemic mixture, which can be easily separated by recrystallization. This enables the production of pure enantiomers, which have higher biological activity and fewer side effects compared to racemic mixtures. In addition to its use in the pharmaceutical industry, DBDTA monohydrate also has applications in the food and cosmetic industries as a chiral reference standard and as a resolving agent for chiral compounds. Overall, DBDTA monohydrate is a valuable tool for the production of pure enantiomers, which play a crucial role in drug development and have significant implications for patient health.

Ruifu Chemical Expands Business with New Electrical Engineer II-IV Positions Ruifu Chemical, a leading supplier of API, pharmaceutical intermediates, chiral compounds, and amino acids, is expanding i

Ruifu Chemical Emerges as a Leading Supplier of High-quality API, Pharmaceutical Intermediates, and Amino Acids Ruifu Chemical, a leading supplier of API, pharmaceutical intermediates, chiral compoun